`
`SANOFI
`
`l
`
`WE ARE
`a global heollhcure leader focused on DaIierIIs‘ needs, eradged in research.
`devebrzment. manufacturing and marketing of healrh praducis, with u diversified
`draw of medicines, vaccines and Innovative therapeuhc solutions.
`
`3
`A MAIN BUSINESS AREAS
`
`CI
`no Imrnunlr
`mIIIIm
`npI.a am prnie-rt
`aga
`I zu Ihl->(IIoIJ¢
`~~
`arse
`
`armcm
`and p
`or IIw=evn,~I< and pan
`
`In Cur'surI19rHealmca'e
`and generics
`
` I
`WO I? LDWI DE
`
`NET SALES 33,770 MILLION EUROS IN 2oI4<I~
`EV BUSINESS")
`
`PHARMACY
`27,720
`
`82.1%
`
`VACCINES
`3,974
`
`’
`11.8%
`
`ANIMAL HEALTH
`2,076
`
`'
`6.1%
`
`4TH
`LARGEST
`PHARMACEUTICAL
`C O M PAN V
`‘N “L55
`
`INNOVATIVE R&D
`
`Dalenlial Iaunchea
`II
`"mm lIIaraL.'elIIII;
`areas be-IV/-:«sIn
`2014 and 2020»
`
`mevlacules and vaccines
`In Ihe deveIo:>menI
`"°'"°I'°
`
`Kacnuw I/3 nu Hm Mnrkis papu|1IIn'I tires nrl have cream <0 cm:
`sumn R caring an 3 ram axes
`
`1:: care pro
`
`¢
`IMPROVING
`ACCESS
`Io MEDICINES
`
`0
`REDUCNG HEALTH
`INE£.|LIALlIl:S
`IHROUGH Irs
`
`Inmorelhcan 80
`0
`.
`.
`=I20r/IOIING
`QIIAIITY CARF 1 mlIIl0n
`BV FIGNIING
`p9cpIe berIeIII;c Irom
`
`'5“A'N'C'§fiE5Pc}(R AGAI~:‘rF§i:I‘J':IFIE~rEII
`
`AN INTERNATIONAL PRESENCE IN +100 COUNTRIES
`
`BV BUSINESS ‘I’
`
`em pIoveet III
`110,000
`
`82.3»;
`
`VACCINES
`
`I
`5_4.,.
`
`7
`
`ANIMAL
`HEALTH
`
`New
`
`
`‘I Document de Rélererus zou
`I Irnésmr preserrlrmon, muuams, zurs
`Product dtvnlspminl pamIm as of Fahruanr 5, ms
`II :
`Reparl am
`‘I I..LI..UI. K] S:xI|oIi FxI§|e|lI.GkIIlVIlIe mm Nlerldl
`
`SANOFI V. GENENTECH
`SANOFI v. GENENTECH
`IPR2015-01624
`IPR2015-01624
`EXHIBIT 2096
`EXHIBIT 2096